News

Filter

Interview: Ferring Pharma’s president Michel Pettigrew on the company’s science-driven growth

Interview: Ferring Pharma’s president Michel Pettigrew on the company’s science-driven growth

18-12-2013

When it comes to being different, privately-owned Ferring Pharma is proud of its culture of enterprise…

BoardroomFerring PharmaceuticalsInterviewsNorthern EuropePharmaceuticalReproductive

Ferring Pharma acquires Cytokine PharmaSciences; Cubist buys Adolor

25-10-2011

Switzerland-based Ferring Pharmaceuticals says that it has completed the purchase of USA-based Cytokine…

AdolorCubist PharmaceuticalsCytokine PharmaSciencesEnteregFerring PharmaceuticalsGastro-intestinalsMergers & AcquisitionsPharmaceuticalReproductive

Women's infertility market set for slow growth due to upcoming patent expiries

02-09-2010

The global women's infertility market was valued at $1.42 billion in 2009 and is forecast to increase…

Ferring PharmaceuticalsMarkets & MarketingMerck SeronoPharmaceuticalReproductive

Ferring acquires Lysteda from Xanodyne, which aims to focus on pain sector; second deal for the firms

11-05-2010

Switzerland-based Ferring Pharmaceuticals has entered an agreement that will expand its Women's Health…

Ferring PharmaceuticalsLicensingLystedaNeurologicalPharmaceuticalReproductiveXanodyne PharmaceuticalsZipsor

COMPANY SPOTLIGHT

Menarini

Back to top